Kalvista Net Interest Income from 2010 to 2026
| KALV Stock | USD 15.61 0.04 0.26% |
Net Interest Income | First Reported 2019-04-30 | Previous Quarter -951 K | Current Value -1.7 M | Quarterly Volatility 758.1 K |
Check Kalvista Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kalvista Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 M, Interest Expense of 0.0 or Selling General Administrative of 4.6 M, as well as many indicators such as Price To Sales Ratio of 46.95, Dividend Yield of 0.0 or Days Sales Outstanding of 273. Kalvista financial statements analysis is a perfect complement when working with Kalvista Pharmaceuticals Valuation or Volatility modules.
Kalvista | Net Interest Income | Build AI portfolio with Kalvista Stock |
The evolution of Net Interest Income for Kalvista Pharmaceuticals provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Kalvista Pharmaceuticals compares to historical norms and industry peers.
Latest Kalvista Pharmaceuticals' Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of Kalvista Pharmaceuticals over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Kalvista Pharmaceuticals' Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kalvista Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
Kalvista Net Interest Income Regression Statistics
| Arithmetic Mean | 856,491 | |
| Geometric Mean | 258,262 | |
| Coefficient Of Variation | 124.47 | |
| Mean Deviation | 803,930 | |
| Median | 650,000 | |
| Standard Deviation | 1,066,062 | |
| Sample Variance | 1.1T | |
| Range | 3.9M | |
| R-Value | 0.64 | |
| Mean Square Error | 718.8B | |
| R-Squared | 0.41 | |
| Significance | 0.01 | |
| Slope | 134,684 | |
| Total Sum of Squares | 18.2T |
Kalvista Net Interest Income History
About Kalvista Pharmaceuticals Financial Statements
Kalvista Pharmaceuticals investors use historical fundamental indicators, such as Kalvista Pharmaceuticals' Net Interest Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Kalvista Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 747.5 K | 1.5 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Kalvista Stock Analysis
When running Kalvista Pharmaceuticals' price analysis, check to measure Kalvista Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalvista Pharmaceuticals is operating at the current time. Most of Kalvista Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kalvista Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalvista Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kalvista Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.